Cogent Biosciences, Inc.

COGT

Exchange: Nasdaq
Industry: Pharmaceutical Preparations
SEC CIK: 0001622229

SEC filings (opens in a new tab)

In the last 90 days, Cogent Biosciences, Inc. insiders filed 0 open-market purchases and 1 sale; 322 institutions reported holding it in 13F filings for Q2 2026, worth $7.50B in total; no superinvestor holds it.

Q3 2025 vs. Q2 2025

How the institutions holding Cogent Biosciences, Inc. changed between Q2 2025 and Q3 2025.

All holders in Q3 2025 All holders in Q2 2025

13F holders of COGT: Q2 2025 compared with Q3 2025
Measure	Q2 2025	Of which not filed for Q3 2025	Q3 2025	Change
Holders	181	2	195	+16
Shares	135.5M	23.3K	159.2M	+23.7M (+17.5%)
Value	$973.2M	$167.2K	$2.29B	+$1.31B (+135.0%)

2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so the changes leave them out.

New holders (40)

Institutions that held Cogent Biosciences, Inc. at the end of Q3 2025 but not at the end of Q2 2025.

Institutions new to COGT in Q3 2025
Institution	Shares	Value	% of portfolio
RTW Investments, LP	3,467,486	$49.8M	0.61%
Balyasny Asset Management LLC	2,670,486	$38.3M	0.08%
Duquesne Family Office LLCSuperinvestorDuquesne Family Office	1,059,580	$15.2M	0.39%
Boone Capital Management LLC	945,042	$13.6M	4.45%
Silverarc Capital Management, LLC	815,075	$11.7M	1.69%
Marshall Wace, LLP	642,479	$9.23M	0.01%
Adage Capital Partners GP, L.L.C.	562,000	$8.07M	0.01%
Logos Global Management LP	500,000	$7.18M	0.71%
Principal Financial Group Inc	272,460	$3.91M	0.00%
Renaissance Technologies LLC	232,968	$3.35M	0.00%
Burkehill Global Management, LP	200,000	$2.87M	0.16%
Jacobs Levy Equity Management, Inc	187,083	$2.69M	0.01%
Jane Street Group, LLC	148,401	$2.13M	0.00%
Holocene Advisors, LP	117,916	$1.69M	0.00%
Cinctive Capital Management LP	111,058	$1.59M	0.08%
Acuta Capital Partners, LLC	102,907	$1.48M	1.53%
Alyeska Investment Group, L.P.	100,000	$1.44M	0.00%
Campbell & CO Investment Adviser LLC	61,634	$885.1K	0.07%
Aquatic Capital Management LLC	57,357	$823.6K	0.02%
Readystate Asset Management LP	49,692	$713.6K	0.03%
Panagora Asset Management Inc	44,042	$632.4K	0.00%
Quadrature Capital Ltd	40,475	$580.8K	0.01%
Optimize Financial Inc	32,552	$467.4K	0.24%
SG Americas Securities, LLC	25,905	$372.0K	0.00%
Bank of Montreal	23,524	$337.8K	0.00%
Capstone Investment Advisors, LLC	20,120	$288.9K	0.00%
Arrowpoint Investment Partners (Singapore) Pte. Ltd.	16,098	$231.2K	0.34%
Sandia Investment Management LP	15,000	$215.4K	0.64%
CIBC Bancorp USA Inc.	13,857	$199.0K	0.00%
SEI Investments Co	11,324	$162.6K	0.00%
Xponance, Inc.	10,142	$145.6K	0.00%
Steward Partners Investment Advisory, LLC	1,859	$26.7K	0.00%
Optiver Holding B.V.	748	$10.7K	0.00%
SRS Capital Advisors, Inc.	374	$5.37K	0.00%
Larson Financial Group LLC	253	$3.63K	0.00%
Smartleaf Asset Management LLC	44	$621	0.00%
Sunbelt Securities, Inc.	40	$574	0.00%
Allworth Financial LP	4	$58	0.00%
Clearstead Advisors, LLC	3	$44	0.00%
FNY Investment Advisers, LLC	14	$0	0.00%

Sold out (24)

Institutions that held Cogent Biosciences, Inc. at the end of Q2 2025 and filed for Q3 2025 without it.

Institutions that sold out of COGT in Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
Vestal Point Capital, LP	3,080,000	$22.1M
Frazier Life Sciences Management, L.P.	1,734,601	$12.5M
Dimensional Fund Advisors LP	569,372	$4.09M
ExodusPoint Capital Management, LP	176,276	$1.27M
Y-Intercept (Hong Kong) Ltd	116,127	$833.8K
Bollard Group LLC	105,059	$754.0K
Squarepoint Ops LLC	101,518	$728.9K
Brevan Howard Capital Management LP	41,481	$297.8K
Birchview Capital, LP	40,000	$287.2K
Aigen Investment Management, LP	33,784	$242.6K
Fox Run Management, L.L.C.	26,385	$189.4K
PDT Partners, LLC	23,668	$169.9K
DRW Securities, LLC	23,194	$166.5K
Cubist Systematic Strategies, LLC	18,230	$130.9K
Corton Capital Inc.	17,438	$125.2K
Oxford Asset Management LLP	15,931	$114.4K
Belvedere Trading LLC	13,727	$98.6K
Sherbrooke Park Advisers LLC	13,038	$93.6K
Two Sigma Securities, LLC	11,428	$82.1K
Skopos Labs, Inc.	6,099	$43.8K
Northwestern Mutual Wealth Management Co	400	$2.87K
US Bancorp	31	$223
Garde Capital, Inc.	10	$72
CBIZ Investment Advisory Services, LLC	3	$22

Not filed for Q3 2025 yet (2)

Institutions that held Cogent Biosciences, Inc. at the end of Q2 2025 and haven't filed a 13F for Q3 2025. Not filing isn't selling, so they aren't counted as sold out.

Institutions holding COGT in Q2 2025 that haven't filed for Q3 2025
Institution	Shares, Q2 2025	Value, Q2 2025
CIBC World Markets Corp	13,081	$93.9K
E Fund Management Co., Ltd.	10,205	$73.3K